Furthermore, the client specificity of E3 ligases is proposed to limit the potential side-effects of drugs that target them, and the new RNF126 structure presented here provides a potential starting point for developing a targeted anti-cancer therapy25, 44, 45. The gene discussed is RNF126; the disease is cancer.